Section Arrow
Quote
XOMA.NASDAQ
- XOMA Royalty Corporation
Quotes are at least 15-min delayed:2026/06/02 10:17 EDT
Regular Hours
Last
 41.565
-0.125 (-0.30%)
Day High 
41.58 
Prev. Close
41.69 
1-M High
42.3 
Volume 
9.32K 
Bid
41.52
Ask
41.61
Day Low
41.45 
Open
41.58 
1-M Low
40.96 
Market Cap 
522.84M 
Currency 美元 
P/E 26.47 
%Yield 1.3 
10-SMA 41.72 
20-SMA 41.67 
50-SMA 38.29 
52-W High 42.81 
52-W Low 22.29 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.57/2.06
Enterprise Value
639.40M
Balance Sheet
Book Value Per Share
9.00
Cash Flow
Cash Flow Yield
0.01
Income Statement
Total Revenue
11.66M
Operating Revenue Per Share
0.93
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
EVGNEvogene Ltd.0.58625-0.09675-14.17%-- 
AIMAIM ImmunoTech Inc.0.817999-0.080601-8.97%-- 
FULCFulcrum Therapeutics3.09-3.33-51.87%-- 
ABVXAbivax SA79.57-50.12-38.65%-- 
OTLKOutlook Therapeutics0.8645+0.0215+2.55%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.